TIDMPVG
RNS Number : 6709E
Premier Veterinary Group PLC
20 July 2016
PREMIER VETERINARY GROUP PLC
("PVG" or "the Company")
APPOINTMENT OF CHIEF FINANCIAL OFFICER
London, UK, 20 July 2016 - Premier Veterinary Group plc (LSE:
PVG) is pleased to announce that Will Evans has been appointed as
Chief Financial Officer and Executive Director of the Company with
effect from 19 September 2016. As announced on 26 April 2016, the
Company's current Chief Financial Officer, Daniel Smith, will be
leaving but will continue working within the business for a period
of time to provide a smooth handover of responsibilities to
Will.
Will Evans joins PVG having previously held a number of senior
management and finance positions in other UK listed companies. From
2009 to 2015, he was at Tribal Group plc where he held roles as
Group Financial Controller, Divisional Finance Director for
Tribal's Services Division and, most recently, as Corporate
Development Director. Prior to joining Tribal Group plc, he was
Group Financial Controller at Synergy Health plc. Will qualified as
a chartered accountant with Arthur Andersen.
There are no disclosures required to be made under LR
9.6.13.
Dominic Tonner, Chief Executive Officer commented:
"I am delighted to have Will join the PVG team. He will further
strengthen the depth of our executive resource as we continue with
our global expansion plans. His skill set will undoubtedly be of
enormous help in delivering value to the Company and its
shareholders."
For further information, please contact:
Premier Veterinary Group plc Tel: +44 (0)117 970 4130
Juliet Thompson, Non-Executive Chairman
Dominic Tonner, Chief Executive Officer
Daniel Smith, Chief Financial Officer
Zeus Capital Limited Tel: +44 (0)203 829 5000
Giles Balleny, Director, Corporate Finance
Hugh Kingsmill Moore, Director, Sales
Square1 Consulting Tel: +44 (0)207 929 5599
David Bick
Brian Alexander
Note to Editors:
PVG's services to third party veterinary practices, through its
wholly-owned subsidiary Premier Vet Alliance Limited ("PVA"),
include the administration and support of a preventative healthcare
program for pets branded "Premier Pet Care Plan" ("PPCP"); and the
operation of a buying group (the "PVA Buying Group") which offers
enhanced discounts to member practices on pharmaceutical and
consumable spending. In the US, Premier Pet Care Plan is marketed
through the Company's wholly-owned subsidiary, Premier Vet Alliance
(US) Limited.
PPCP is a structured, preventative healthcare program for cats,
dogs and rabbits and is available only through veterinary
practices. The program is seen as a way of providing gold standard
care for pets at an affordable price for the client, by way of
fixed monthly payments.
PPCP uses a clinical approach to prevention, as this is the most
effective method of ensuring illnesses are diagnosed more quickly
and not given a chance to advance. What truly sets PPCP apart is
its unique approach of offering an end-to-end solution and support
to the practice, which has been proven to work extremely well. PVA
works alongside practices to create a tailor-made, cost-effective
service for clients, one that delivers excellent care to their
patients and significantly improves practice performance.
The PVA Buying Group, is now the UK's largest veterinary buying
group without group interests in veterinary practices or veterinary
wholesalers offering its members the best discounts across the
industry on pharmaceutical and consumable spend.
For further details: http://www.premiervetalliance.co.uk/
This announcement includes "forward-looking statements" which
include all statements other than statements of historical facts,
including, without limitation, those regarding the Company's
financial position, business strategy, plans and objectives of
management for future operations, and any statements preceded by,
followed by or that include forward-looking terminology such as the
words "targets", "believes", "estimates", "expects", "aims",
"intends", "will", "can", "may", "anticipates", "would", "should",
"could" or similar expressions or the negative thereof. Such
forward-looking statements involve known and unknown risks,
uncertainties and other important factors beyond the Company's
control that could cause the actual results, performance or
achievements of the Company to be materially different from future
results, performance or achievements expressed or implied by such
forward-looking statements. Such forward-looking statements are
based on numerous assumptions regarding the Company's present and
future business strategies and the environment in which the Company
will operate in the future. These forward-looking statements speak
only as at the date of this announcement. The Company expressly
disclaims any obligation or undertaking to disseminate any updates
or revisions to any forward-looking statements contained in this
announcement to reflect any change in the Company's expectations
with regard thereto or any change in events, conditions or
circumstances on which any such statements are based. As a result
of these factors, readers are cautioned not to rely on any
forward-looking statement.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDBGDRLBBBGLC
(END) Dow Jones Newswires
July 20, 2016 02:00 ET (06:00 GMT)
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Sep 2023 to Sep 2024